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Behavioral/Systems/Cognitive

Central Amygdala Metabotropic Glutamate Receptor 5 in the
Modulation of Visceral Pain
Lara W. Crock,1,2,3,4* Benedict J. Kolber,2,4,5,6* Clinton D. Morgan,2,4 Katelyn E. Sadler,5,6 Sherri K. Vogt,2,4
Michael R. Bruchas,1,2,4 and Robert W. Gereau IV1,2,4
Program in Neuroscience, 2Department of Anesthesiology, 3Medical Scientist Training Program, and 4Washington University Pain Center, Washington
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University, Pittsburgh, Pennsylvania 15282

1

Painful bladder syndrome is a debilitating condition that affects 3– 6% of women in the United States. Multiple lines of evidence suggest
that changes in CNS processing are key to the development of chronic bladder pain conditions but little is known regarding the underlying
cellular, molecular, and neuronal mechanisms. Using a mouse model of distention-induced bladder pain, we found that the central
nucleus of the amygdala (CeA) is a critical site of neuromodulation for processing of bladder nociception. Furthermore, we demonstrate
that metabotropic glutamate receptor 5 (mGluR5) activation in the CeA induces bladder pain sensitization by increasing CeA output.
Thus, pharmacological activation of mGluR5 in the CeA is sufficient to increase the response to bladder distention. Additionally, pharmacological blockade or virally mediated conditional deletion of mGluR5 in the CeA reduced responses to bladder distention suggesting
that mGluR5 in the CeA is also necessary for these responses. Finally, we used optogenetic activation of the CeA and demonstrated that
this caused a robust increase in the visceral pain response. The CeA-localized effects on responses to bladder distention are associated
with changes in extracellular signal-regulated kinases 1/2 (ERK1/2) phosphorylation in the spinal cord. Overall, these data demonstrate
that mGluR5 activation leads to increased CeA output that drives bladder pain sensitization.

Introduction
Visceral pain is the most common reason that patients seek
medical attention and the most common form of pain produced by disease (Cervero and Laird, 1999). Visceral pain associated with interstitial cystitis or painful bladder syndrome
(PBS/IC) affects 3– 8 million women in the United States
(Berry et al., 2011), yet PBS/IC is poorly understood and
treated (Dimitrakov et al., 2007). Up to 91% of these patients
carry a diagnosis of another chronic disorder such as chronic
fatigue, migraine, fibromyalgia, anxiety, and/or depression
(Warren et al., 2009). Factors such as stress and depression
(Macaulay et al., 1987; Baldoni et al., 1995) increase PBS/IC
pain, and chronic pain is associated with increases in both
stress and depression. Activity in the amygdala, a primary
limbic structure, is positively correlated with stress, anxiety,
and pain behavior (Neugebauer et al., 2004; Carrasquillo and
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Gereau, 2007; Ikeda et al., 2007; Ji et al., 2007; Neugebauer,
2007). The fact that emotion and stress modulate visceral pain
and that the amygdala processes stress and nociceptive signals
suggests that the amygdala is involved in the pathogenesis of
chronic visceral pain.
The central nucleus of the amygdala (CeA) receives both
indirect and direct nociceptive information (Bernard and
Besson, 1990; Burstein and Potrebic, 1993; Bernard et al.,
1996; Bourgeais et al., 2001). Noxious colorectal distention
increases c-fos expression in the CeA (Traub et al., 1996), and
the excitability of CeA neurons increases after induction of
colitis in rats (Han and Neugebauer, 2004). Afferent outputs
from the CeA to the hypothalamus and brainstem regions such
as the periaqueductal gray (PAG) also make the amygdala well
positioned to modulate responses to painful stimuli. Activation of the CeA with chronic corticosterone implants increases
visceromotor responses to distention in rats (Greenwood-Van
Meerveld et al., 2001; Myers and Greenwood-Van Meerveld,
2010). However, it is undetermined whether acute changes in
excitability of CeA neurons modulate the response to noxious
bladder stimulation.
The excitability of neurons in the CeA during visceral stimulation is modulated in part by metabotropic glutamate receptor 5
(mGluR5) (Li and Neugebauer, 2004). mGluR5 activation of extracellular signal regulated kinases 1/2 (ERK1/2) has been hypothesized to play a role in the modulation of pain responses (Ji,
2004; Kolber et al., 2010). Pharmacological activation of mGluR5
in the CeA increases rectal distention-induced neuronal responses (Ji and Neugebauer, 2010) and behavioral vocalizations
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(Li et al., 2011). However, it is unknown whether mGluR5 in the
CeA plays a key role in bladder pain.
Here, we used right amygdala-specific pharmacological activation and inhibition of mGluR5 as well as conditional deletion
of mGluR5 to determine the role of CeA-specific mGluR5 signaling in bladder pain. Next, we used optogenetic approaches to
stimulate CeA neurons to determine whether increased activation of the CeA neurons increases the visceromotor response to
noxious bladder distention. Overall, we demonstrate that either
mGluR5 activation in the CeA or optogenetic activation of the
CeA is sufficient to sensitize responses to painful bladder distention; we have identified a novel role for mGluR5 in the ongoing
control of acute visceral pain.

Materials and Methods
Animals
All mouse protocols were in accordance with National Institutes of
Health guidelines and were approved by the Animal Care and Use Committees of Washington University (St. Louis, MO) and Duquesne University (Pittsburgh, PA). Female mice (all C57BL/6J background), aged
10 –13 weeks, were housed on a 12 h light/dark schedule with ad libitum
access to rodent chow and water. Unless otherwise noted, wild-type
(WT) mice were used for all experiments.

Visceromotor response to urinary bladder distention
The visceromotor response (VMR) is a spinobulbospinal reflex to
bladder distention that has been validated as a measure of pain, as the
response is suppressed by analgesics and potentiated by bladder inflammation. The VMR is observed in decerebrate rodents and not in
rodents with a transected spinal cord (Castroman and Ness, 2001;
Ness et al., 2001; Ness and Elhefni, 2004) but can also be modulated by
higher brain centers (Qin et al., 2003). Bladder distention reliably
produces pain and/or discomfort in humans (Ness et al., 1998) and is
frequently used in rodents as a model of visceral pain. Procedures for
bladder distention and VMR recording were similar to those previously described (Lai et al., 2011) (for illustration of setup, see Fig.
1 A). Experimenter was blinded to treatment and/or genotype in all
experiments. Briefly, on the day of VMR recording, the mice were
anesthetized with 2% isoflurane. Chlorinated silver wire electrodes
were placed on the external oblique abdominal muscle and subcutaneously across the abdominal wall (as a ground) to allow differential
amplification of the abdominal VMR signals. A lubricated angiocatheter was inserted into the bladder via the urethra for bladder distention. After surgical preparation, isoflurane was reduced to ⬃1.0%
until a flexion reflex response was present (evoked by pinching the
paw), but spontaneous escape behavior and righting reflex were absent. The use of low levels of isoflurane during urinary bladder distention (UBD) has been validated previously (Ness and Elhefni,
2004). After the desired level of anesthesia was achieved, the level of
isoflurane was not changed for the duration of the experiment. The
animals were not restrained in any fashion and body temperature was
maintained using an overhead radiant light and monitored throughout the experiment. Phasic bladder distention with compressed air
was then used to evoke bladder nociception. The air pressure was
controlled by an automated distention control device custom-made
in the Washington University School of Medicine Electronic Shop (St.
Louis, MO). The distention stimulus applied was 20 – 80 mmHg pressure for 20 s with 2 min intertrial interval (ITI). The precise pressure
gradient used varied depending on the specific experiment (see Results). The VMR signal was relayed in real time using a Grass CP511
preamplifier (Grass Technologies) to a PC via a WinDaq DI-720 module (Dataq Instruments). Data were exported to Igor Pro 6.05 software (Wavemetrics). Using a custom script, the VMR signals were
subtracted from the baseline, rectified, and integrated over 20 s to
quantify the evoked response.

Surgical procedure for cannula implantation
WT mice were cannulated as previously described (Kolber et al., 2010).
Briefly, mice were deeply anesthetized with a combination ketamine/
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xylazine anesthetic and mounted in a stereotaxic frame. An 8.00 mm
stainless-steel guide cannula was implanted above the right CeA (coordinates: 1.25 mm anterior to bregma; 2.70 mm lateral to midline; 4.2 mm
ventral to skull). The guide cannula was affixed to the skull with two bone
screws and dental cement. An 8.00 mm stylet was inserted in the guide
cannula to prevent clogging. Mice recovered for 3 d [for herpes simplex
virus (HSV) optogenetic experiments] or 6 d (for pharmacological experiments) before further testing. At the end of experiments, brains were
sectioned to verify cannula position and injection site. Briefly, for all
experiments, the cannula end was verified by histological or visual analysis (under 4⫻ magnification). This included first using a mouse stereotaxic atlas (Paxinos and Franklin, 2001) and the hippocampus as a
rostral– caudal guide to identify the brain section corresponding to the
tip of the cannula. Next, a determination of correct CeA targeting was
done by using the internal branch of the external capsule and the optic
tract as markers for the lateral and medial aspects of the CeA. The center
of the cannula target was verified by looking at serial sections across the
extent of the cannulated area. For Western experiments in which only 1
mm sections were analyzed, the section was cut directly over the cannula
tract and punches were made on either side of the cannula tip after visual
verification of CeA targeting. For experiments described in this manuscript, we have included insets in figures that show cannula tip placements. In all experiments, the right amygdala only was targeted for
manipulation because previous results from both mice (Carrasquillo and
Gereau, 2008; Kolber et al., 2010) and rats (Ji and Neugebauer, 2009; Li et
al., 2011) have shown a specific lateralization of the right amygdala in
somatic and visceral pain.

Intra-amygdala drug infusion
Mice were cannulated targeting the right amygdala as described
above. Six days after cannulation surgery, drugs were infused. Microinjections were performed as previously described (Carrasquillo and
Gereau, 2007). Briefly, injections were performed using a 32 gauge
injection cannula that extended 0.5 mm beyond the tip of the guide
cannula. The injection cannula was attached to flexible plastic tubing,
and a microliter syringe (Hamilton) was used to deliver drug or vehicle. A total volume of 0.3 l was infused over a period of 3 min and
the injection cannula was kept in place for an additional 1 min to
allow for drug diffusion.
Drugs injected included (RS)-3,5-dihydroxyphenylglycine (DHPG)
and 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP). DHPG
(Tocris) is an agonist that activates both mGluR5 and mGluR1. On the day of
the experiment, DHPG was dissolved in artificial CSF (aCSF) (25 mM
NaHCO3, 122 mM NaCl, 1.3 mM CaCl2, 1.2 mM MgSO4, 3 mM KCl, and 0.4
mM KH2PO4, pH 7.35) as a 5 mM stock solution, which was diluted in aCSF
to 0.1 nmol (final injected volume, 0.3 l). Mice were treated with DHPG 30
min following baseline distention and then distended again 30 min after
treatment. MPEP (Tocris) is a selective noncompetitive antagonist of
mGluR5. On the day of the experiment, MPEP was dissolved in aCSF as a
stock 5 mM solution, which was diluted in aCSF to a final concentration of
0.01 nmol (final injected volume, 0.3 l). For bladder distention experiments with baseline distention, mice were treated with MPEP (or vehicle)
immediately following baseline distention and then distended again 60 min
after treatment. For bladder distention experiments with no baseline distention, mice were treated with MPEP (or vehicle) 60 min before bladder distention at 80 mmHg. Dosing and timing for DHPG and MPEP was derived
from our previous studies examining amygdala-induced somatic hypersensitivity (Kolber et al., 2010).

Preparation of CeA-specific mGluR5 knock-out mice
(mGluR5 CeAKO)
Mice homozygous for the mGluR5loxP allele (Xu et al., 2009) or WT
littermates were used. All animals were injected in the right amygdala
with virus containing recombinant lentiviral vector LV-Ef1␣-Cre (LVCre) as previously described (Kolber et al., 2008, 2010). Briefly, mice
were anesthetized with a combination ketamine/xylazine anesthetic and
mounted in a stereotaxic frame. A small hole was drilled over the right
CeA (coordinates: 1.25 mm anterior to bregma; 2.7 mm lateral to midline; 4.7 mm ventral to skull). A 32 gauge needle was lowered into the
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hole, and 4 ⫻ 10 5 infectious viral particles were injected over 5 min. The
injection needle was kept in place after injection for 4 min to allow for
stable diffusion. All testing in these mice occurred 2 weeks after recovery
from surgery. After testing, brains were sectioned to determine needle
targeting and 1 mm diameter ⫻ 1 mm high punches were made of the
amygdala in two adjacent sections to determine amount of mGluR5
protein disrupted in mGluR5 CeAKO mice compared with WT mice injected with LV-Cre. In addition, tissue from the lumbosacral spinal cord
was harvested for analysis of ERK phosphorylation. See below for a description of processing of tissue samples.

Optogenetic vectors, infusion, and stimulation parameters
Vectors. HSV vectors were obtained from McGovern Institute (Massachusetts Institute of Technology, Boston, MA). Briefly, HSV vectors
driven by the CMV promoter [channelrhodopsin hChR2(H134R)-EYFP
or EYFP only] were prepared as previously described (Neve et al., 2005;
Covington et al., 2010). All experiments were performed on day 4 after
infection because maximal expression of HSV vectors occurs on days 3– 4
(Covington et al., 2010).
Vector infusion. Mice were cannulated in the right amygdala as described above. Three days after cannulation surgery, HSV vectors were
infused. Microinjections were performed similarly to that described
above for drugs. A total volume of 1 l was infused over a period of 5 min,
and the injection cannula was kept in place for an additional 1 min to
allow for viral infusion.
Optogenetic CeA stimulation during bladder distention. On the day of
the experiment, an 8.00 mm fiber optic fiber (0.2 mm diameter; Thor
Labs) was placed in the animal’s cannula. Optic stimulation was performed similar to previously published protocols (Covington et al., 2010;
Zhang et al., 2010). Briefly, the fiber optic was connected via a FC/PC
adaptor to a 473 nm blue laser diode (OEM) connected to a power
supply. Laser pulses were controlled using a Techtronix pulse generator.
During all stimulations, a 5 ms, 20 Hz (18 ms spike width) pulse train was
delivered for 30 min. The stimulation protocol was modeled to mimic the
firing pattern of CeA neurons that occurs after painful injury in rodents
(Ji and Neugebauer, 2009). The intensity of the fiber optic light was
verified before and after each experiment use using a luxometer (Thor
Labs). For the distention experiment, we applied a bladder stimulus of 30
mmHg (20 s, three times, with 2 min ITI), and then 60 mmHg (20 s, three
times, with 2 min ITI) during baseline testing, 20 min after the laser was
turned on, and 15 min after the laser was turned off. For Western blot and
immunohistochemistry experiments, mice were stimulated with the laser
as above for 30 min and then killed 15 min after laser off with no distention. Mice were killed after the experiment and analyzed by immunohistochemistry and Western blotting for targeting, ERK phosphorylation,
and/or eYFP expression (see below).

Western blotting

Protein expression in mGluR5CeAKO mice. After bladder distention (see
above), spinal cords were removed by hydraulic extrusion from
mGluR5 CeAKO mice (compared with LV-Cre-injected WT mice). The
lumbosacral portion of the spinal cord that is innervated by bladder
afferent input (L6 –S1) was isolated by (1) identifying the thickest portion of the lumbar enlargement as L4/L5, (2) measuring 2 mm caudal to
this portion as the start of L6, and then (3) isolating a section of cord that
started at this L6 point and continuing 7 mm caudal. This method of
identification has been validated by our immunohistochemical analysis
of pERK1/2 in the dorsal horn after bladder distention (Lai et al., 2011).
That is, the Western “lumbosacral” isolates used in this experiment correspond to the immunohistochemical sections that stain positive for
phosphorylated ERK1/2 after bladder distention. After the lumbosacral
portion of the spinal cord was isolated, the tissue was frozen on dry ice.
Brains were removed, sectioned into 1-mm-thick coronal sections using
an acrylic brain matrix (Stoelting), and amygdala punches (two per side
per animal) were obtained using a custom-made 1 mm punch tool and
frozen on dry ice. All tissue samples were homogenized with ice-cold
homogenization buffer (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM
sodium pyrophosphate, 25 mg/ml aprotinin, 25 mg/ml leupeptin, and
100 mM phenylmethylsulfonyl fluoride). The levels of mGluR5 in the left
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or right amygdala were measured by Western blotting using antibodies
specific for mGluR5 and the loading control protein ␤-Tubulin. Total
protein (7.5 g) for amygdala homogenates was separated using 4 –12%
SDS-PAGE and transferred to nitrocellulose membranes. For mGluR5
Western blotting, membranes were blocked in Odyssey blocking buffer
for 1 h and then coincubated in mouse anti-␤-Tubulin (1:10,000; SigmaAldrich) and rabbit anti-mGluR5 (1:1000; Millipore) primary antibodies
in Odyssey buffer with 0.1% Tween 20 for 1 h at room temperature (RT).
After washing in TBS with 0.1% Tween 20, blots were incubated in goat
anti-mouse IR800 (1:20,000; Sigma-Aldrich) and goat anti-rabbit Alexa
Fluor 680 (1:20,000; Sigma-Aldrich) for 1 h at RT. Blots were washed and
scanned using an Odyssey infrared scanner. Densitometry of bands corresponding to mGluR5 and ␤-Tubulin was performed using Odyssey
software (version 3.0). Each mGluR5 band was divided by the pixel value
for the ␤-Tubulin value of that sample and then normalized to the left
amygdala because our previous results showed that mGluR5 protein is
increased in the right amygdala compared with the left amygdala (Kolber
et al., 2010). The levels of ERK1/2 phosphorylation in the spinal cord
were measured by Western blotting using antibodies specific for phosphorylated ERK and for total ERK. Total protein (5 g) for spinal cord
homogenates was run as described above. Blots were blocked as above
and then coincubated in mouse anti-p44/42 ERK (1:1000; Cell Signaling)
and rabbit anti-phospho-p44/42 ERK (1:1000; Cell Signaling) primary
antibodies in Odyssey buffer with 0.1% Tween 20 (Sigma-Aldrich) for 1 h
at RT. Final processing was done as above. Densitometry of bands corresponding to ERK1 ( p44) and ERK2 ( p42) was performed using Odyssey, version 3.0, software (LI-COR).
Bladder distention induced ERK1/2 activation. All mice (sham undistended and distended) were anesthetized and catheterized as described
above for urinary bladder distention testing. Distended animals received
20 s, 80 mmHg bladder distention stimulation (five times with 2 min
ITI). Mice were killed 5 min after last bladder distention (or equivalent
amount of time for sham mice). Spinal cords and brains were processed
as above. Westerns were done as above on spinal cord and amygdala
tissue for phosphorylated ERK and for total ERK.
Optogenetically induced spinal cord ERK1/2 phosphorylation. Mice were
anesthetized and catheterized as described above for urinary bladder
distention testing. All mice [HSV-EYFP and HSV-hChR2(H134R)EYFP] received 30 min of stimulation using the optical stimulation protocol described above. Fifteen minutes following termination of optical
stimulation, mice were killed, and spinal cord was processed as above.
Western blotting was completed using spinal cord tissue and assessing
levels of phosphorylated ERK1/2 and total ERK1/2.

Immunohistochemistry
YFP CeA expression. Following the optogenetic bladder stimulation experiment (described above), mice were deeply anesthetized with pentobarbital, perfused transcardially with PBS (37°C), followed by 25 ml of
ice-cold 4% paraformaldehyde (PFA) solution in PBS. The brain was
dissected and postfixed in PFA overnight at 4°C. After cryoprotection in
30% sucrose, coronal sections (30 m) were obtained on a cryostat and
stored in PBS at 4°C until immunostaining. Sections were rinsed in TBS
and blocked in 1% BSA/0.2% milk/0.1% Triton X-100 for 1 h at RT.
Sections were incubated overnight at 4°C in rabbit anti-GFP antibody
(1:2000; Invitrogen) in blocking solution. Sections were rinsed in TBS
with 0.1% Triton X-100 and incubated in donkey anti-rabbit Alexa Fluor
555 secondary antibody (1:250; Invitrogen) in blocking solution for 1 h at
RT. Sections were rinsed in TBS with 0.2% Triton X-100, TBS, and then wet
mounted and visualized using a Nikon Eclipse80i fluorescent microscope.
Optogenetically induced spinal cord ERK1/2 phosphorylation. Following
optogenetic CeA stimulation (described above), mice were deeply anesthetized with pentobarbital then perfused with PBS (37°C) followed by
ice-cold 4% PFA. The spinal cord was removed and the L4 –S2 region was
isolated. Samples were fixed in 4% PFA for 4 h, followed by 30% sucrose
for 48 h, both at 4°C. Thirty-micrometer transverse sections were cut on
a cryostat, and then immediately placed in PBS. Representative sections
from L6 –S1 of the spinal cord were rinsed in PBS, and then placed in
1.0% sodium borohydride for 10 min. Following additional rinses, sections were washed in PBS with 0.1% Triton X-100, and then rinsed again.
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Figure 1. Intra-amygdala DHPG results in bladder hyperalgesia. A, Illustration of in vivo urinary bladder distention VMR setup. Compressed air guided into the bladder with a catheter is used to distend the
bladder.DistentioninducesavisceromotorresponsethatisrecordedasanEMGfromtheabdominalmuscles.RepresentativeEMGtracesshowthattheVMRresponseincreaseswithincreasingbladderdistention
pressure.B,MicearecannulatedintherightCeA,anddrugisdeliveredviathecannula.C,InfusionofanmGluR1/5agonist,DHPG(0.1nmol),intotherightCeA(n⫽7)inducesahyperalgesicresponsetograded
bladder distention compared with baseline (pretreatment) values. EMG inset shows representative EMG trace to 50 mmHg distention at baseline and following DHPG treatment (step represents 20 s distention
stimulus). Brain atlas insets show cannula targeting with black stars indicative of cannula tip. D, Treatment with intra-amygdala vehicle (aCSF) (n ⫽ 7) had no effect on the evoked response to graded bladder
distention.Brainatlasinsetsshowcannulatargetingwithwhitestarsindicativeofcannulatip(***p⬍0.001,two-wayANOVAmaineffectoftreatment;*p⬍0.05,Bonferroni’sposttestcomparedwithbaseline
value). Error bars indicate SEM. BLA, Basolateral amygdala; CeL, lateral division of CeA; CeLC, laterocapsular division of CeA; CeM, medial division of CeA.
Sections were blocked in 5% normal goat serum with PBS containing 0.1%
Triton X-100, 1% BSA, and 0.1% fish gelatin at RT for 1 h. Exposure to rabbit
anti-pERK (1:200; Cell Signaling) occurred overnight at 4°C in 1.5% NGS
blocking solution. Sections were rinsed in PBS then incubated with goat
anti-rabbit Alexa Fluor 488 antibody (1:200; Invitrogen) in 1.5% NGS blocking solution at RT for 1 h. After a final rinse, sections were wet mounted and
visualized using a Nikon Microphot-SA microscope. pERK was quantified in
four L6 –S1 sections for each animal. For cell counts, each spinal cord section
was divided into four main regions as previously established (Lai et al., 2011):
deep dorsal commissure, spinal parasympathetic nuclei, lateral dorsal horn,
and medial dorsal horn. The total number of cells in each region was counted
for each section. For each animal, an average cell count was determined using
the four sections so that presented data represent the average number of
positive cells per section per mouse. All spinal cords were removed and
processed on the same day. Sections from all animals were stained at the
same time. The researcher who performed the cell counts was blinded to the
treatment groups.

Data analysis

Results are expressed as means ⫾ SEM. Student’s t tests were used to
compare pairs of means. In cases of two independent variables (e.g.,
genotype and pressure), two-way ANOVA with repeated measures was
used followed by Bonferroni’s post hoc tests when significant main effects
were found. A value of p ⬍ 0.05 was considered statistically significant for
all statistical comparisons. All statistical comparisons were performed
with Prism 5 software (GraphPad).

quantified using the VMR, which is an electromyographic (EMG)
recording of the abdominal muscle contraction in response to bladder distention (Ness and Gebhart, 1988, 1991; Ness and Elhefni,
2004). Previous studies have demonstrated a critical role for
mGluR5 activation in the right amygdala in the development of
somatic pain sensitization (Ji and Neugebauer, 2009; Kolber et al.,
2010), but it is not known whether mGlu5 also regulates bladder
nociception. To address this question, the selective mGluR1/5 agonist, DHPG, was infused to the right amygdala via an indwelling
cannula (Fig. 1B) and the effects of this infusion on the VMR to
bladder distention were measured. Bladder distention (20 – 80
mmHg distention in 10 mmHg steps) reliably produces an evoked
VMR that increases with increasing distention pressure (Fig. 1A; C,
two-way ANOVA main effect of pressure, F(6,42) ⫽ 8.2, p ⬍ 0.0001;
D, F(6,42) ⫽ 26.3, p ⫽ 0.0019). When a control vehicle is infused, and
the bladder distention protocol is repeated, no changes in the evoked
response are observed (Fig. 1D). In contrast, infusion of DHPG (0.1
nmol) significantly increased the evoked responses to bladder distention compared with pretreatment baseline values (Fig. 1C; twoway ANOVA significant main effect of treatment, F(1,42) ⫽ 26.3, p ⬍
0.0001; before DHPG vs after DHPG Bonferroni’s post hoc test at 50
mmHg, t ⫽ 2.9, p ⬍ 0.05). Thus, activation of mGluR1/5 in the right
CeA results in significant physiological sensitization to bladder
distention.

Results
Amygdala mGluR activation induces bladder hypersensitivity
To study pain-like behavior originating from the bladder as directly
as possible, we chose to study the response to urinary bladder distention (Fig. 1A). The behavioral response to bladder distention is

Intra-amygdala mGluR5 antagonism decreases evoked
responses to bladder distention
Prior evidence suggested that mGluR5 in the amygdala is involved in the modulation of somatic pain only after injury and
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that mGluR5 signaling does not affect
acute responses to noxious stimulation
(Kolber et al., 2010; Li et al., 2011).
Whether mGluR5 modulates acute responses to bladder stimulation is not
known, however. To address the role of
amygdala mGluR5 in the modulation
of bladder pain, the mGluR5 antagonist
MPEP (or vehicle) was delivered locally to
the right amygdala between two rounds of
bladder distentions (from 20 to 80 mmHg
in 10 mmHg increments), and the effects
on the evoked VMR were determined. We
found that MPEP infusion to the CeA induced a significant decrease in bladder
distention-evoked responses (two-way
ANOVA significant main effects of pressure, F(6,35) ⫽ 5.9, p ⫽ 0.0003, and treatment, F(1,35) ⫽ 22.45, p ⬍ 0.0001) that was
particularly noticeable at the higher noxious pressures (Fig. 2A; before MPEP vs
after MPEP Bonferroni’s post hoc test at 70
mmHg, t ⫽ 4.5, p ⬍ 0.001, and at 80
mmHg, t ⫽ 6.1, p ⬍ 0.001) compared
with baseline VMRs. These results were
corroborated in a second experiment in
which we measured the effect of pretreatment with MPEP on the VMR to a single
round of noxious distention of the bladder with no baseline distention. We found
that mice that had received infusion of
MPEP into the right CeA had significantly
decreased VMR to high noxious (80
mmHg) bladder distention when compared
with responses in vehicle-infused mice (Fig.
2C; Student’s t test, t(11) ⫽ 2.3, p ⫽ 0.04).
These findings provide further support for
the notion that mGluR5 activation in the
amygdala is required for acute regulation of
bladder nociception.
Surprisingly, when vehicle was infused
between two rounds of graded bladder
4

Figure 2. Intra-amygdala MPEP is analgesic during bladder distention. A, Infusion of a mGluR5 antagonist, MPEP (0.01 nmol),
into the right CeA (n ⫽ 6) induced an analgesic response to graded bladder distention in the noxious range compared with baseline
(pretreatment) values. The inset shows representative EMG traces to 70 and 80 mmHg distention at baseline and following MPEP

treatment (step represents 20 s distention stimulus). Brain atlas insets show cannula targeting with black stars indicative of
cannula tip. B, Treatment with intra-amygdala injection of vehicle (aCSF) (n ⫽ 6) induced a significant increase in evoked
response during bladder distention. However, this change was
in the opposite direction of treatment with MPEP and likely
represents a small nonspecific effect possibly due to repeated
bladder distention. Brain atlas insets show cannula targeting
with white stars indicative of cannula tip. C, In a separate cohort, pretreatment with MPEP (n ⫽ 7) before a single round of
higher noxious pressure bladder distention (i.e., no baseline
distention) induced a significant decrease in the evoked response compared with vehicle-treated mice (n ⫽ 6). Brain
atlas insets show cannula targeting with solid black stars indicative of cannula tip of MPEP-treated mice and white stars
indicative of cannula tip of vehicle-treated mice (***p ⬍ 0.001,
two-wayANOVAmaineffectoftreatment; ⫹⫹⫹p⬍0.001,Bonferroni’s post test compared with indicated baseline value; *p ⬍
0.05, Student’s t test compared with vehicle-treated group). Error
bars indicate SEM.
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distention, the evoked responses were significantly increased relative to preinfusion baseline measurements (Fig. 2 B;
two-way ANOVA significant main effects
of pressure, F(6,35) ⫽ 5.0, p ⫽ 0.0009, and
treatment, F(1,35) ⫽ 15.4, p ⫽ 0.0004).
These results might suggest that repeated
distention to noxious pressures can induce mild sensitization of the bladder. To
address this issue, we examined the VMR
in control mice that received only a single
round (four to five distentions) of 80
mmHg distention (with no baseline
UBD). Comparing the VMR after the first
distention at 80 mmHg in these mice to
the last distention, we found no significant sensitization of the VMR to repeated
distentions (first distention, 0.54 ⫾ 0.10
evoked response; last distention, 0.30 ⫾
0.05 evoked response; paired t test, t(5) ⫽
1.9, p ⫽ 0.11). These data suggest that
repeated bladder distention does not sensitize the bladder.
Disruption of mGluR5 in the right
amygdala reduces responses to
bladder distention
The results described above demonstrate
that pharmacological activation of mGluR5
in the right CeA enhances the evoked response to bladder distention, whereas inhibition of mGluR5 in the CeA inhibits these
responses. These data are consistent with
the hypothesis that mGluR5 in the right
CeA plays a central role in the endogenous
modulation of visceral bladder pain. However, pharmacological manipulations in
vivo can always have the potential for offtarget effects. To complement our pharmacological studies, we took a genetic
approach to test the hypothesis that endogenous mGluR5 activation is required for
bladder pain. A conditional knock-out
approach was used to specifically disrupt
mGluR5 expression in the right CeA using recombinant lentivirus-mediated expression of Cre recombinase (LV-Cre) in
floxed mGluR5 mice. Floxed mGluR5 mice
injected with LV-Cre (mGluR5 CeAKO) ex- Figure 3. Lentivirus-mediated conditional disruption of mGluR5 in the central amygdala is analgesic. A, Representative WestCeAKO
and WT LV-Cre-injected (control) mice. Graph of mGluR5/␤hibited a significant decrease in mGluR5 ern blot for mGluR5 (top) and ␤-tubulin (bottom) in mGluR5
tubulin
shows
reduced
mGluR5
expression
in
the
right
amygdala
of mGluR5 CeAKO mice (n ⫽ 8) compared with the right amygdala
protein levels when compared with
mGluR5 expression in the right amygdala of of control mice (n ⫽ 8). B, Disruption of mGluR5 in the right amygdala (n ⫽ 8) induced a significant decrease in evoked response
with black squares
LV-Cre-injected WT (control) mice, thus during bladder distention compared with control mice (n ⫽ 9). Brain atlas insets show cannula targeting
indicative of cannula tips of control mice and gray triangles indicative of cannula tips of mGluR5 CeAKO mice (***p ⬍ 0.001,
confirming deletion of mGluR5 (Fig. 3A; two-way ANOVA main effect of genotype; **p ⬍ 0.01, Student’s t test). Error bars indicate SEM.
Student’s t test, t(9) ⫽ 3.8, p ⫽ 0.0045). To
measure the impact of CeA mGluR5 disrupsuggest that mGluR5 activity in the CeA modulates ongoing sensition on bladder pain-related behavior, we compared the responses of
tivity to visceral stimulation.
CeAKO
mGluR5
with control mice during graded bladder distention
(distention from 20 to 80 mmHg in 10 mmHg steps). We found a
Amygdala control of bladder hyperalgesia is associated with
significant decrease in the evoked response to bladder distention in
ERK activation in the spinal cord
the mGluR5 CeAKO mice compared with control mice (Fig. 3B; twoway ANOVA significant main effects of pressure, F(6,105) ⫽ 7.8, p ⬍
Next, we sought to evaluate the mechanisms by which activation
0.0001, and genotype, F(1,105) ⫽ 14.4, p ⫽ 0.0003). Overall, these data
of the CeA might modulate evoked responses to bladder disten-
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nificant decrease in the phosphorylation
of ERK1 and ERK2 in the spinal cord after
bladder distention compared with distended control mice (Fig. 5 A, B; Student’s
t test, pERK1, t(14) ⫽ 2.3, p ⫽ 0.038;
pERK2, t(14) ⫽ 2.3, p ⫽ 0.035). These data
suggest the presence of tonic modulation
of spinal circuitry driven by mGluR5 activation in the CeA. In contrast, when we
compared the phosphorylation of ERK1
and ERK2 by Western analysis in the spinal cord after CeA treatment with MPEP
or vehicle followed by a single round of
noxious distention, we failed to find any
significant differences between groups
(data not shown).
Optogenetic activation of the central
Figure 4. Bladder distention induces spinal cord ERK phosphorylation. A, Representative Western blot showing phosphorylated amygdala is sufficient to induce pain
ERK1 and ERK2 bands (top) and total ERK1 and ERK2 (bottom) from spinal cord tissue of undistended control (sham) mice (n ⫽ 7) hypersensitivity with no changes in
or 80 mmHg bladder distended mice (n ⫽ 7). B, Quantification of Western blots showing increased ERK1 and ERK2 phosphoryla- ERK1/2 phosphorylation
tion in distended mice compared with sham mice. C, Representative Western blot showing phosphorylated ERK1 and ERK2 bands The mechanisms through which mGluR5
(top) and total ERK1 and ERK2 (bottom) from left and right amygdala of sham mice or 80 mmHg bladder-distended mice. D, in the CeA might modulate responses to
Quantification of Western blots showing no significant change ERK1 and ERK2 phosphorylation from right amygdala tissue sam- bladder distention are unknown. For
ples of distended mice compared with sham mice (*p ⬍ 0.05, **p ⬍ 0.01, unpaired Student’s t test compared with sham group). example, mGluR5 activation in the CeA
Error bars indicate SEM.
could suppress a tonically active descending inhibitory pathway to the spinal cord,
or conversely could drive increased descending excitatory circuitry. To address
the hypothesis that an overall increase in
the activity of CeA neurons may be sufficient to induce bladder hyperalgesia,
we used an optogenetic approach to drive
excitation of CeA neurons and asked
whether this increased CeA activity could
modulate the VMR elicited by innocuous
and noxious bladder distention.
To accomplish this goal, channelFigure 5. Genetic disruption of mGluR5 in the right amygdala reduces bladder distention-induced ERK phosphorylation. A,
rhodopsin-2
or control protein expression
Representative Western blot showing phosphorylated ERK1 and ERK2 bands (top) and total ERK1 and ERK2 (bottom) from spinal
cord tissue from LV-Cre-injected control mice (n ⫽ 9) or mGluR5 CeAKO mice (n ⫽ 7) following graded bladder distention. B, was driven in the CeA by targeted injection
Quantification of Western blots showing decreased ERK1 and ERK2 phosphorylation in mGluR5 CeAKO mice compared with control in the right CeA (Fig. 6A) of HSV vectors
expressing YFP only (HSV-YFP control;
mice (*p ⬍ 0.05, unpaired Student’s t test compared with control group). Error bars indicate SEM.
Fig. 6B) or channelrhodopsin-2 fused to
YFP (HSV-ChR2-YFP; Fig. 6C). Four days
tion. We hypothesized that mGluR5 activation in the CeA could
after viral injection, mice were stimulated with low (30 mmHg) or
modulate bladder nociception by regulating ERK1/2 activity in
with higher noxious (60 mmHg) bladder distention at baseline, durthe CeA or spinal cord (through modulation of descending pathing, and after laser stimulation (5 ms, 20 Hz pulse with 18 ms spike
ways). We first tested whether bladder distention in naive mice
width). The optical stimulation protocol chosen for these experiwould induce ERK1/2 phosphorylation. We compared the proments was modeled to mimic the CeA neuronal firing pattern that
tein collected from the lumbosacral spinal cord and the CeA in
occurs after injury in rodents (Ji and Neugebauer, 2009). In HSVmice distended five times at 80 mmHg with protein from undisYFP control mice, optical stimulation did not alter evoked responses
tended sham mice. We found that bladder distention induced a
to bladder distention at 30 mmHg (Fig. 6D,F) or 60 mmHg (Fig.
significant increase in phosphorylated ERK1 and ERK2 in the
6G,I). In contrast, 30 min of optical stimulation of HSV-ChR2-YFPspinal cord (Fig. 4 A, B; Student’s t test, pERK1, t(12) ⫽ 2.6, p ⫽
treated mice caused a significant increase in bladder distention0.022; pERK2, t(12) ⫽ 3.3, p ⫽ 0.0068). In contrast, we found no
evoked responses compared with baseline measurements (Fig. 6E,F;
significant change in activation of ERK1 or ERK2 in the CeA
H,I, Bonferroni’s post hoc test at 30 mmHg, t ⫽ 2.5, p ⬍ 0.05, and at
following distention compared with sham mice (Fig. 4C,D).
60 mmHg, t ⫽ 4.3, p ⬍ 0.001) and compared with HSV-YFP control
Since bladder distention induced an increase in activated
mice (Fig. 6I; Bonferroni’s post hoc test at 60 mmHg, t ⫽ 3.0, p ⬍
ERK1/2 in the spinal cord and we found a decrease in the evoked
0.05). Interestingly, CeA stimulation induced a lasting hypersensiresponse to bladder distention in mGluR5 CeAKO mice, we reativity to bladder distention in HSV-ChR2-YFP-treated mice. That is,
soned that mGluR5 CeAKO mice might show a decrease in spinal
15 min after the laser stimulation was terminated, HSV-ChR2-YFPERK1/2 activation following bladder distention. Indeed, we
treated mice still showed increased responses to bladder distention
found that disruption of mGluR5 in the right CeA caused a sig(Fig. 6E,F; Bonferroni’s post hoc test at 30 mmHg compared with
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baseline, t ⫽ 2.8, p ⬍ 0.05; H,I, at 60 mmHg
compared with baseline, t ⫽ 4.6, p ⬍ 0.001,
and at 60 mmHg compared with HSV-YFP
control mice, t ⫽ 3.1, p ⬍ 0.05).
To test one possible downstream effect
of optogenetic activation of the amygdala,
we evaluated whether optogenetically
driven activation of the amygdala (5 ms,
20 Hz pulse with 18 ms spike width) in the
absence of bladder distention would induce spinal cord ERK1/2 phosphorylation. Mice received local infusions in the
CeA of HSV-ChR2-YFP or HSV-YFP as
described above. Four days after viral infusion, mice were anesthetized and stimulated with the laser on for 30 min and
were killed after the laser had been off for
15 min. Comparing spinal cord protein
samples analyzed by Western or spinal
cord sections analyzed for pERK1/2 immunofluorescence, we found that optogenetic stimulation of the CeA failed to
induce an increase in ERK1/2 phosphorylation compared with HSV-YFP control
mice (Western: Student’s t test, pERK1
HSV-YFP, n ⫽ 12, 1.0 ⫾ 0.08, vs HSVChR2-YFP, n ⫽ 10, 1.0 ⫾ 0.09, t ⫽ 0.1,
p ⫽ 0.93; pERK2 HSV-YFP, 1.0 ⫾ 0.07, vs
HSV-ChR2-YFP, 1.1 ⫾ 0.07, t ⫽ 0.7, p ⫽
0.51) (IHC: Student’s t test, deep dorsal
commissure, HSV-YFP, n ⫽ 3, 40.0 ⫾
10.6, vs HSV-ChR2-YFP, n ⫽ 3, 38.9 ⫾
5.5, pERK1/2-positive cells, t ⫽ 0.10,
p ⫽ 0.92; spinal parasympathetic nuclei,
HSV-YFP, 23.0 ⫾ 8.9, vs HSV-ChR2YFP, 29.5 ⫾ 2.3, pERK1/2-positive cells,
t ⫽ 0.82, p ⫽ 0.45; lateral dorsal horn,
HSV-YFP, 12.6 ⫾ 2.4, vs HSV-ChR2YFP, 13.2 ⫾ 4.1, pERK1/2-positive cells,
t ⫽ 0.11, p ⫽ 0.91; medial dorsal horn,
HSV-YFP, 15.3 ⫾ 6.9, vs HSV-ChR2YFP, 16.6 ⫾ 3.8, pERK1/2-positive cells,
t ⫽ 0.18, p ⫽ 0.86; total dorsal horn, HSVYFP, 90.8 ⫾ 25.6, vs HSV-ChR2-YFP,
98.1 ⫾ 12.7, pERK1/2-positive cells, t ⫽
0.28, p ⫽ 0.79). Similar to our results with
optogenetic activation, treatment of the
CeA with DHPG in the absence of bladder distention did not alter ERK1/2
phosphorylation in the spinal cord
compared with vehicle-treated mice
(data not shown).

Discussion
Our results demonstrate that activation of
group I mGluRs in the right amygdala was
sufficient to induce an increased pain
response to bladder distention. Furthermore, pharmacological inhibition and genetic deletion of mGluR5 in the right
amygdala resulted in a reduced response
to bladder distention. Optogenetic activation of the right amygdala was sufficient to
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Figure 6. Optogenetic stimulation of right central amygdala induces bladder hyperalgesia. A, Mice are cannulated in the right
CeA and HSV vectors are delivered via the cannula. B, C, YFP fluorescence (via immunohistochemistry) is seen in the CeA of both
HSV-YFP (control vector) (B) and HSV-ChR2-YFP (optogenetic vector)-injected mice (C). Scale bars, 0.2 mm. Differences in staining
pattern for HSV-YFP- versus HSV-ChR2-YFP-treated mice are likely due to the fact that there is probably higher expression of
cytoplasmic YFP (i.e., HSV-YFP) compared with the ChR2-YFP fusion protein, which is membrane bound. Brain atlas insets show
cannula targeting with black squares indicative of cannula tips of HSV-YFP mice and white hexagons indicative of cannula tips of
HSV-ChR2-YFP mice. Representative images of raw EMG traces from HSV-YFP- or HSV-ChR2-YFP-injected mice during 30 mmHg
(D, E) and 60 mmHg (G, H) bladder distention. Optic stimulation of HSV-ChR2-YFP-treated mice (n ⫽ 7) increases the evoked
response to both 30 and 60 mmHg bladder distention compared with baseline (prestimulation) responses (E, H) and increases the
evoked response to 60 mmHg bladder distention compared with HSV-YFP-injected mice (n ⫽ 5) (I). Laser light alone does not
increase the evoked response to bladder distention in HSV-YFP mice (D, F, G, I). The black steps in traces show 20 s bladder
distention stimuli (*p ⬍ 0.05; ***p ⬍ 0.001, Bonferroni’s post test compared with baseline for HSV-ChR2-YFP mice; #p ⬍ 0.05,
Bonferroni’s post test compared with HSV-YFP control mice at indicated time points). Error bars indicate SEM.
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increase the pain response to bladder distention. Together, these
results suggest that mGluR5 in the right CeA modulates bladder
pain responses via increased excitation of CeA neurons. Our results are consistent with previous work demonstrating that noxious bladder distention in the absence of injury results in ERK1/2
activation in the lumbosacral spinal cord (Lai et al., 2011). Furthermore, we found that the level of activated ERK1/2 is dependent on the presence of mGluR5 in the right CeA. Our results
suggest that distention-evoked ERK1/2 activation in the lumbosacral spinal cord is modulated in part by mGluR5 activity in the
right amygdala.
Here, we show for the first time that mGluR5 in the right CeA
is necessary for the visceral bladder pain response to noxious
stimuli. Our results are consistent with previous work indicating
that activation of group I mGluRs in the right amygdala leads to
increased somatic pain (Kolber et al., 2010). Specifically, activation of mGluR5 in the right amygdala results in bilateral mechanical hypersensitivity (Kolber et al., 2010). Our results extend this
phenomenon to visceral bladder pain and suggest that pharmacological activation of group I mGluRs (mGluR1 and -5) in the
right CeA is sufficient to increase the nociceptive responses to
bladder distention in naive (noninjured) mice.
Given that previous studies have shown the mGluR1/5 agonist
DHPG potentiates the excitatory response of the CeA during
visceral colorectal distention (Ji and Neugebauer, 2010), we hypothesized that activation of group I mGluRs in the amygdala
could lead to increased excitability as has been reported previously (Li and Neugebauer, 2004), thus resulting in the observed
increased response to bladder distention. We demonstrate that
optogenetic stimulation of CeA neurons in the right amygdala is
sufficient to increase the VMR to urinary bladder distention. Furthermore, this increased VMR is maintained 15 min after the
optogenetic activation is turned off. Injury in a colitis model
increases the excitability of evoked responses in the CeA (Han
and Neugebauer, 2004) and arthritis-induced somatic injury increases the background and evoked responses of CeA neurons (Li
and Neugebauer, 2004). The sustained behavioral response we
observe after optical excitation suggests that 30 min activation of
the CeA may, in effect, model the changes seen after either visceral or somatic injury. Future studies are required to test this
hypothesis.
Our previous studies have shown that inhibition of mGluR5
in the right amygdala reduces persistent injury-induced hypersensitivity of the paw, but that inhibition of mGluR5 does not
alter acute somatic sensitivity or spontaneous somatic nociceptive responses (Kolber et al., 2010). Here, we find that pharmacological inhibition of mGluR5 following a round of bladder
distention is analgesic when compared with the baseline bladder
distention. These results could represent either a novel role of
mGluR5 in modulating acute visceral sensation or provide additional evidence that mGluR5 modulates sensation after mild injury caused by repeated bladder distentions. We believe that the
significant increase in the evoked response in the vehicle-treated
mice (Fig. 2 B) is likely a statistical aberration as no such effect was
seen in a similar experiment (Fig. 1 D), and we found that the first
VMR is not significantly different from the last VMR during a
round of noxious bladder distention with no baseline testing.
Nonetheless, to unequivocally determine whether mGluR5 in the
CeA modulates baseline (uninjured) responses to bladder distention, we inhibited mGluR5 before noxious stimulation with no
baseline distention trials. Providing evidence for the hypothesis
that mGluR5 modulates acute bladder nociception, mice pretreated with MPEP have a smaller VMR in response to a single
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round of 80 mmHg distention when compared with vehicletreated mice. This hypothesis is further supported by the reduced
VMR observed in mice with conditional disruption of mGluR5 in
the right amygdala, because these animals receive only a single
series of distentions. Interestingly, these data are contrary to previous reports showing that inhibition of mGluR5 in the right
amygdala has no effect on vocalizations induced by visceral colorectal distention (Li et al., 2011). One possible explanation for
this apparent discrepancy is that there are inherent differences in
the responses measured [e.g., vocalizations (Li et al., 2011) vs
reflexive abdominal contractions]. Our novel results demonstrate that ongoing mGluR5 activity in the right CeA modulates
the visceromotor response to noxious bladder distention in naive
(uninjured) mice.
The mechanism of the modulation of distention-evoked bladder pain by CeA-localized mGluR5 seems to be related in part to
a modulation of ERK1/2 in the spinal cord. Our previous experiments have demonstrated that ERK1/2 in both the spinal cord
and amygdala is involved in the modulation of acute spontaneous
somatic pain and behavioral changes after injury (Carrasquillo
and Gereau, 2007, 2008; Hu et al., 2007). Furthermore, we know
from previous work that ERK1/2 is activated in the dorsal horn
neurons of the lumbosacral spinal cord (lamina I, II, V, X) following bladder distention in mice with and without bladder inflammation (Lai et al., 2011). Our results suggest that noxious
bladder distention in lightly anesthetized mice immediately activates ERK1/2 in the lumbosacral spinal cord, but not in the
amygdala. Furthermore, genetic deletion of mGluR5 in the right
CeA reduced activation of ERK1/2 in the lumbosacral spinal cord
following bladder distention. In contrast, pharmacologic inhibition of mGluR5 with MPEP did not change the activation of
ERK1/2 following noxious distention. This difference may be
related to the long-term disruption that exists in the knock-out
mice compared with the acute inhibition in the MPEP experiment, or a difference in the extent of mGluR5 inhibition achieved
by the two approaches. Nonetheless, these data suggest the presence of a functional connection between the amygdala and the
spinal cord nociceptive neurons.
To further test this connection, we activated the amygdala (via
optogenetic or pharmacologic techniques) in the absence of bladder distention and measured ERK1/2 phosphorylation in the spinal cord. Finding no effect of amygdala activation on pERK1/2 in
the spinal cord, these results suggest either that ERK1/2 modulation occurs only in the context of nociceptive input (e.g., bladder
distention) and/or that there are other changes that occur in the
spinal cord during amygdala activation. Nociceptive neurons in
the CeA project to the PAG and then to the rostral ventromedial
medulla (RVM) (Neugebauer et al., 2004). Descending inputs
from the RVM exert facilitatory and inhibitory influence on nociceptive transmission in the spinal cord dorsal horn (Millan,
2002; Porreca et al., 2002; Ren and Dubner, 2002). Modulation of
visceral nociception between the amygdala and the spinal cord
could occur at the sensory fiber/spinal cord synapse (in the spinal
cord dorsal horn), on modulatory interneurons, or potentially on
motor neurons that mediate abdominal contractions during
bladder distention. Future studies will be necessary to determine
the precise location and mechanism of this interaction.
Overall, our results suggest that increased CeA output, driven
by mGluR5 activation, in combination with bladder distention
leads to modulation of ERK activation in the spinal dorsal horn.
These results highlight the important role that limbic brain structures play in the regulation of peripheral responses to noxious
stimuli. Furthermore, our results showing that mGluR5 inhibi-
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tion modulates acute visceral nociception provide evidence for a
novel role of the amygdala in the modulation of ongoing nociception in the absence of injury or external stress.
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